000			01652nam a2200565 i 4500
003			CtWfDGI
020			_a0851996175
040			_aCtWfDGI _cCtWfDGI
082	0	4	_a616.9/6061
245	0	0	_aMacrocyclic lactones in antiparasitic therapy
260			_aUK _bCAB International _c2002
300			_a1 online resource (xiv, 432 pages) :
500			_aCAB International
546			_aEnglish
650		0	_aAvermectins.
650		0	_aLactones.
650		0	_aMacrocyclic compounds.
650		0	_aAntiparasitic agents.
650		4	_aPesticides and Drugs; Control, (New March 2000)
650		4	_aPesticide and Drug Resistance.
650		4	_aProtozoan, Helminth, Mollusc and Arthropod Parasites of Animals, (New March 2000)
650		4	_aVeterinary Pharmacology and Anaesthesiology, (New March 2000)
650		4	_aProtozoan, Helminth and Arthropod Parasites of Humans, (New March 2000)
650		7	_aCats.
650		7	_aCattle.
650		7	_aDogs.
650		7	_aGoats.
650		7	_aHorses.
650		7	_aMan.
650		7	_aPigs.
650		7	_aRuminants.
650		7	_aSheep.
650		7	_aAnthelmintics.
650		7	_aAntiparasitic agents.
650		7	_aDisease control.
650		7	_aDrug resistance.
650		7	_aDrug therapy.
650		7	_aIntroduced species.
650		7	_aLactones.
650		7	_aMode of action.
650		7	_aPets.
650		7	_aPharmacokinetics.
650		7	_aPharmacology.
650		7	_aResistance mechanisms.
650		7	_aSafety.
700	1		_aVercruysse, J.
700	1		_aRew, Robert S.,
856	4	0	_uhttp://dx.doi.org/10.1079/9780851996172.0000
942			_2ddc _cEB
999			_c140473 _d140473